China Regenerative Medicine International Limited (HKG:8158)

HKG:8158 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	158	90	167	317	799	1,627
Market Cap Growth	-46.36%	-46.36%	-47.18%	-60.36%	-50.88%	789.56%
Enterprise Value	189	139	237	377	822	1,762
Last Close Price	0.52	0.29	0.55	1.11	2.80	5.70
PE Ratio	8.92	5.06	-	69.56	15.42	-
PS Ratio	1.75	0.99	2.41	7.63	2.83	8.93
PB Ratio	6.28	3.56	14.19	3.05	7.15	-29.50
P/TBV Ratio	6.28	3.56	14.19	3.05	7.15	27.99
P/FCF Ratio	8.95	5.08	15.91	-	-	-
P/OCF Ratio	8.64	4.90	15.51	-	-	-
EV/Sales Ratio	2.09	1.53	3.41	9.08	2.91	9.67
EV/EBITDA Ratio	11.07	20.41	-	31.49	13.33	-
EV/EBIT Ratio	30.83	22.62	-	31.94	13.34	-
EV/FCF Ratio	10.70	7.85	22.50	-	-	-
Debt / Equity Ratio	2.13	2.13	4.26	0.69	0.32	-0.78
Debt / EBITDA Ratio	3.14	3.14	-	4.19	0.58	-
Debt / FCF Ratio	3.04	3.04	4.77	-	-	-
Asset Turnover	0.56	0.56	0.30	0.16	1.38	0.52
Inventory Turnover	96.81	96.81	136.97	11.68	244.23	34.58
Quick Ratio	0.87	0.87	1.09	1.52	1.41	0.61
Current Ratio	0.99	0.99	1.14	1.58	1.75	0.71
Return on Equity (ROE)	95.98%	95.98%	-186.16%	4.23%	183.20%	-
Return on Assets (ROA)	2.38%	2.38%	-7.07%	2.76%	18.72%	-1.03%
Return on Capital (ROIC)	5.45%	5.45%	-13.72%	4.56%	56.82%	-2.28%
Return on Capital Employed (ROCE)	8.00%	8.00%	-	10.00%	55.10%	-
Earnings Yield	11.22%	19.78%	-64.36%	1.44%	6.49%	-24.85%
FCF Yield	11.17%	19.70%	6.28%	-4.74%	-0.48%	-24.53%
Buyback Yield / Dilution	-6.23%	-6.23%	-0.34%	-	-77.64%	-82.73%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.